“provenge” Archives

Entry Author Date Location
Dendreon CEO John Johnson: ‘This is My Last Stop’ 04/17/12 Seattle
J&J Prostate Cancer Drug Hits Goal; Hurts Dendreon, Helps Medivation 03/08/12 New York
Dendreon Adds ImClone Vets to New Management Team 02/28/12 Seattle
Dendreon Stock Tumbles As Company Projects ‘Moderate’ Sales Growth 02/27/12 Seattle
Dendreon Names John Johnson CEO After Volatile Year 02/01/12 Seattle
Dendreon Surprises With $82M in Fourth Quarter Sales, Stock Booms 01/05/12 Seattle
Dendreon Pulls In $125M By Selling Royalty Slice of Merck’s Hepatitis C Drug 12/06/11 Seattle
Medivation, Astellas Prostate Cancer Drug Helps Men Live Longer; Shares Skyrocket 11/03/11 San Francisco
Dendreon Shares Tank Again, Elias Joins Gates Foundation, Seattle Children’s Gets $50M, & More Seattle-Area Life Sciences News 11/03/11 Seattle
Dendreon Edges Past Street Expectations With Third Quarter Provenge Sales, Shares Still Fall 11/02/11 Seattle
Chris Henney, the Immunex and Dendreon Mover/Shaker, Makes Biotech Hall of Fame 10/17/11 Seattle
Dendreon Concentrates Job Cuts in Manufacturing, but Seattle Feels the Axe Too 09/08/11 Seattle
Dendreon Whacks 500 Jobs, 25% of Workforce, After Missing Sales Goal 09/08/11 Seattle
Theraclone Sniffs Around for $10M, Dendreon Gets Third Factory OK, Zymeworks’ Big Merck Deal, & More Seattle-Area Life Sciences News 09/08/11 Seattle
(Mis)Understanding Drug Discovery: It’s Much Harder Than Rocket Science 09/07/11 Seattle
Dendreon Wins FDA OK for Atlanta Provenge Factory, Completing National Network 08/26/11 Seattle
Dendreon Adds Ex-ImClone CEO to Board 08/22/11 Seattle
Dendreon Wounds Are Self-Inflicted, Not the Start of a Biotech Industry Virus 08/08/11 National
An Open Letter to Dendreon’s Chairman 08/05/11 Seattle
Dendreon Takes Huge Hit, Stock Tanks 60% on Sales Shortfall 08/03/11 Seattle
Dendreon Misses Street Expectations, Plans Layoffs, Backs Away from Bullish Forecast 08/03/11 Seattle
Stop the M&A Obsession: Biotech Needs More Companies to Stay Independent 07/18/11 National
Dendreon, After Yearlong Inquiry, Sways Medicare to Pay for $93,000 Prostate Cancer Drug 06/30/11 Seattle
Gates Bets on Computer Drug Discovery, Tachi Yamada Joins Frazier, Dendreon’s LA OK, & More in Seattle-Area Life Sciences News 06/30/11 Seattle
Dendreon Gets FDA Nod for New LA Cancer Drug Factory 06/29/11 Seattle
Exelixis Zeroes in on Lead Drug, Sees Activity in the Bones of Prostate Cancer Patients 06/06/11 San Francisco
Accelerator’s New Startup, Oncofactor, Seeks to Spark Immune System Fight Against Cancer 05/24/11 Seattle
The Resurgence of Gene and Cell Therapy 05/16/11 Seattle
Kleiner Perkins’ Bet on a Concrete Stomach, The Gates Foundation’s Out-of-the-Box Ideas, & More Seattle-Area Life Sciences News 05/05/11 Seattle
Dendreon Gets $28M Revenue in Q1 05/02/11 Seattle
Page 2 of 6 « previous page · next page »